April 2009
Volume 50, Issue 13
Free
ARVO Annual Meeting Abstract  |   April 2009
Wnt/β-Catenin Signaling in Diabetic Retinopathy
Author Affiliations & Notes
  • X.-Q. Song
    Surgery,
    University of Chicago, Chicago, Illinois
  • S.-Y. Park
    Medicine,
    University of Chicago, Chicago, Illinois
  • Q. Zhang
    Pathology,
    University of Chicago, Chicago, Illinois
  • Y. A. Lussier
    Medicine,
    University of Chicago, Chicago, Illinois
  • R. H. Xing
    Pathology,
    University of Chicago, Chicago, Illinois
  • M. A. Grassi
    Surgery,
    University of Chicago, Chicago, Illinois
  • Footnotes
    Commercial Relationships  X.-Q. Song, None; S.-Y. Park, None; Q. Zhang, None; Y.A. Lussier, None; R.H. Xing, None; M.A. Grassi, None.
  • Footnotes
    Support  KL2RR025000, Research to Prevent Blindness, International Retinal Research Foundation, Knights Templar Eye Foundation,
Investigative Ophthalmology & Visual Science April 2009, Vol.50, 2910. doi:
  • Views
  • Share
  • Tools
    • Alerts
      ×
      This feature is available to authenticated users only.
      Sign In or Create an Account ×
    • Get Citation

      X.-Q. Song, S.-Y. Park, Q. Zhang, Y. A. Lussier, R. H. Xing, M. A. Grassi; Wnt/β-Catenin Signaling in Diabetic Retinopathy. Invest. Ophthalmol. Vis. Sci. 2009;50(13):2910.

      Download citation file:


      © ARVO (1962-2015); The Authors (2016-present)

      ×
  • Supplements
Abstract

Purpose: : Recent genetic and biochemical evidence suggests that the Wnt/ß-catenin pathway may be involved in the pathogenesis of diabetic retinopathy, which is a leading cause of blindness. Here we report Wnt/β-catenin alterations in high glucose cell assays.

Methods: : Cell cultures: TR-iBRB (rat retinal endothelial) cells were cultured, respectively, in 5mM glucose/DMEM/ECGF/10% FBS or 25mM glucose/DMEM/ECGF/0.5% human albumin for control and experimental treatments. For 3D cultures, 104 cells were cultured in Matrigel in a 4-well chamber slide under 5mM or 25mM glucose/DMEM, 0.5% human albumin for 2 weeks.Western blot: Western blots using antibodies against GSK-3β, phospho-Ser9-GSK-3β, β-catenin, cyclin D1, and GAPDH were performed. Real-time PCR: Total RNA was isolated with a Qiagen RNeasy kit. For cDNA synthesis, 1µg RNA was used in 20µl. Real-time PCR was performed in 25µl with ABI 7900 Real-time PCR System.

Results: : High glucose reduces tube formation: In 3D, cells in the 25mM glucose medium revealed less sprouting, branching, tubulogenesis and capillary surface area compared with the 5mM glucose medium after 7 days.Biphasic response: Western blot data showed that the β-catenin protein level was elevated initially after being treated with 25mM glucose for 1 to 4 hrs; 18 hrs later the β-catenin levels declined below baseline. Levels of GSK-3β, an upstream regulator of β-catenin, were compatible with this biphasic response. High glucose affects target gene transcription of β-catenin: Real-time PCR demonstrated that the mRNA of two downstream products of β-catenin signaling, cyclin D1 and VEGFa, are increased initially after treatment with 25mM glucose; 24 hours later, mRNA levels returned to baseline.

Conclusions: : High glucose exposure results in a biphasic response in both β-catenin and GSK3β signaling in TRiBRB cells. Further, high glucose treatment inhibited TRiBRB cell sprouting and forming tube-like structures in Matrigel 3-D culture. These findings suggest that Wnt/β-catenin signaling is likely an important player in regulating retinal angiogenesis in response to high glucose insult frequently seen in diabetic patients.

Keywords: retina • diabetes • signal transduction 
×
×

This PDF is available to Subscribers Only

Sign in or purchase a subscription to access this content. ×

You must be signed into an individual account to use this feature.

×